Most colorectal carcinomas harbor genetic alterations that result in stabilization of b-catenin. A colorectal carcinoma cell line, HCT116, which has both mutated and wild-type b-catenin genes, was engineered by homologous recombination to investigate the significance of b-catenin gene mutation. As expected, the mutant allele-targeted clones showed decreased b-catenin expression and downregulation of T-cell factor (TCF)/lymphoid enhancer factor (LEF)-dependent transcription. Morphologically, targeted clones were only minimally altered under usual culture conditions, but under low serum conditions, mutant alleletargeted clones still grew in plane, in contrast to parental cell line and wild allele-targeted clones, which formed spheroids. The mutant allele-targeted clones showed no significant changes in growth rate and anchorage-independent growth in vitro, and displayed rather increased growth in vivo. Although b-catenin stabilization affects some biological characteristics including adhesive properties, it may not have growth-promoting effects at least in some colorectal carcinomas.
Introduction b-Catenin is a submembranous component of the adherence junction, and also acts as a transcriptional activator of the Wnt signaling pathway. Genetic alterations of genes involved in b-catenin degradation, including mutations of b-catenin, APC (adenomatous polyposis coli), Axin1 and Axin2 (Axil), have been reported in various tumors (Liu et al., 2000; Polakis, 2000; Satoh et al., 2000) . These mutations stabilize bcatenin by inhibiting proteosomal degradation triggered by glycogen synthase kinase-3b (GSK-3b)-dependent phosphorylation of serine/threonine residues at the N-terminus of b-catenin. Stabilization of bcatenin is considered to have transformation activity, and overexpression of wild-type or mutant b-catenin has been reported to affect morphology, anchorageindependent growth, contact inhibition and immortalization (Nagasawa et al., 1999; Orford et al., 1999; Wagenaar et al., 2001) .
Stabilization of b-catenin by mutational inactivation of APC or by b-catenin gene mutation is found in most colorectal adenomas and carcinomas . In animal experimental models, mice with genetically engineered APC or b-catenin have been shown to cause adenoma formation (Shibata et al., 1997; Harada et al., 1999) . The stabilized b-catenin promotes TCF/LEF-dependent transcription and upregulates target genes, including c-myc, cyclin D1, matrilysin, gastrin and multidrug resistance 1 (MDR1) (He et al., 1998; Crawford et al., 1999; Tetsu and McCormick, 1999; Koh et al., 2000; Yamada et al., 2000) . The participation of matrilysin and gastrin in adenoma formation has been demonstrated by knockout mouse experiments (Wilson et al., 1997; Koh et al., 2000) . Thus, mutational analyses of clinical specimens and experiments with transgenic mice have proved the importance of b-catenin stabilization in adenoma formation, which is the earliest event of colorectal carcinogenesis.
On the other hand, the significance of these genetic alterations in the progressed colorectal carcinomas remains to be clarified. There are reports describing growth-suppressive or apoptotic effects of b-catenin downregulation in colon cancer cell lines (Shih et al., 2001; Roh et al., 2001) . If downregulation of stabilized bcatenin effectively suppresses the growth of colorectal cancers, it should be a promising therapeutic target because of their high frequency of b-catenin stabilization by genetic alterations. However, previous experiments were performed in an overrexpression-based system, which could cause oversuppression of b-catenin beneath the level in normal cells. Recently, application of the gene targeting technique to somatic cells enabled us to investigate the molecular function of oncogenes in a more physiological manner (Shirasawa et al., 1993; Sedivy and Dutriaux, 1999) . Here, we conducted an experiment based on the gene targeting method to investigate the significance of b-catenin gene mutation. Using this method, we could specifically disrupt the mutated b-catenin gene without affecting the wild-type allele. This might result in downregulation of the bcatenin level in colorectal cancer cells to the level of normal cells controlled by endogenous promoter.
Results

Generation of b-catenin gene-targeted cell lines
Transfection of the targeting vector ( Figure 1a ) to 3610 6 cells typically yielded 20 -40 puromycin-resistant colonies. By PCR analysis, amplification products of approximately 1300 bp were detected in 12 clones of 336 puromycin-resistant colonies tested. These PCR-positive clones were subjected to Southern blot analysis and sequencing to confirm the homologous recombination. Southern blot analysis revealed the expected fragments in all PCR-positive clones ( Figure  1b) .
As parental HCT116 cells harbor wild-type and mutated (deletion of codon 45) b-catenin genes, sequencing of exon 3 resulted in an overlapped sequence from codon 45 ( Figure 1c ). As our targeting vector lacked exon 3, sequencing of targeted cell lines revealed only the remaining allele ( Figure 1c) . As a result, the wild-type allele was disrupted in seven clones and the mutant allele was disrupted in five. Among them, six clones, including three wild-type alleledisrupted clones (clones 12m, 31m, 76m) and three mutant allele-disrupted clones (clones 8w, 55w, 95w) were subjected to further investigation. These six clones were derived from different dishes in transfection, and were therefore independently targeted clones.
Morphology of the targeted clones in vitro
The morphology of these clones was almost identical under the usual culture conditions, except that mutant allele-disrupted clones showed somewhat irregular colony margins with noticeable cell projections ( Figure  2 ). However, under low serum conditions, mutant allele-targeted clones still grew in plane, in contrast to parental cells and wild-type allele-disrupted clones, which grew as spheroids and were easily detached from the culture dish (Figure 2) . Figure 4a (clones 95w, 76m: data not shown). There was no difference in growth rate and saturation density irrespective of mutational status of the b-catenin gene. The soft agar colonyforming assay showed no alteration in anchorageindependent growth, either in number or area of colonies (Figure 4b ). The subcutaneous tumor weight of each clone at 2 weeks after inoculation in nude mice is presented in Figure 4c . Mutant allele-targeted clones showed significantly increased in vivo growth compared with wild-type allele-targeted clones and the parental cell line.
Discussion
Mutation of the b-catenin gene in HCT116 involves serine at codon 45, which is one of the residues typically mutated in various tumors (Polakis, 2000) . This is one of the four serine/threonine residues that are phosphorylated by GSK-3b, and mutations involving these residues are considered to prevent phosphorylation by GSK-3b and subsequent proteosomal degradation. In the present experiment, a decreased level of b-catenin protein was observed in the mutant allele-targeted clones, confirming stabilization of mutant b-catenin protein in both soluble and insoluble fractions. This decrease of b-catenin protein level was paralleled by downregulation of TCF/ LEF-dependent transcription. We examined the mRNA level of some of the reported TCF/LEF target genes, including cyclin D1, c-myc and MDR1, by Northern blotting analysis, but none of them showed significant alteration (data not shown). These genes may not be upregulated by b-catenin gene mutation in parental HCT116 cells.
The decreased mRNA level in each targeted clone compared with parental HCT116 cells is of interest. We assume that this difference is based on the number of alleles in each cell line; parental cells have two alleles of the b-catenin gene and targeted cells have only one allele. Our result suggests that the level of b-catenin protein is not affected by transcription and that the bcatenin gene is transcribed from each allele irrespective of its protein level. As previously suggested, expression of b-catenin protein may be physiologically regulated by protein degradation.
In the present study, disruption of the mutated bcatenin gene caused no growth disadvantage in vitro. However, two groups have reported that downregulation of b-catenin protein inhibits in vitro growth or causes apoptosis in colorectal carcinoma cell lines (Shih et al., 2001; Roh et al., 2001) . Although these observations seem to conflict with our results, this discrepancy could be explained by differences in the mode of b-catenin downregulation. In those reports, bcatenin was suppressed by overexpression of APC or by a b-catenin antisense oligonucleotide, which might downregulate b-catenin below the level of normal cells. These results might indicate the importance of physiological b-catenin expression, but not directly reflect the importance of b-catenin stabilization by genetic alteration. On the other hand, the present result seems to be in agreement with our previous report that suppression of TCF4-dependent transcription in the DLD-1 colon carcinoma cell line resulted in no alteration in the in vitro growth rate (Naishiro et al., It was an unexpected result for us that mutant alleletargeted clones showed not suppressed, but rather increased, tumorigenicity in nude mice. We have also examined tumor growth at 4 weeks after inoculation. Although the tumors formed showed prominent central necrosis, probably as a result of excessive enlargement of the tumors, the mutant allele-targeted clones similarly tended to be larger (data not shown). Judging from the unaltered growth in vitro and unaltered anchorage-independent growth, non-cell-autonomous factors such as cancer-stromal interaction could be a possible cause of this advantage. The different morphology under low serum culture conditions might also represent some effects on cell adhesion to matrix. Shirasawa et al. (1993) have reported that targeted disruption of the mutant K-ras gene in HCT116 cells considerably suppresses growth in vitro and the capability for anchorage-independent growth and growth in nude mice. These drastic changes indicate important roles of the mutant K-ras gene in malignant phenotypes of this cell line, and are in contrast to the relatively minor biological effect of mutant b-catenin gene disruption in the present study. Our results suggest that stabilization of b-catenin affects some characteristics possibly including cancer -stromal interaction, but does not play a major role in cell growth, at least in some colorectal carcinomas. Considering the ordered sequential mutations in multistep colorectal carcinogenesis, it is possible that stabilization of bcatenin is essential in adenoma formation but less important in carcinomas with multiple additional genetic alterations. Because Wnt signaling is physiologically involved in the developmental process, upregulated Wnt signaling by b-catenin stabilization may also have effects on the differentiation of colocytes. For example, a recent report described that down-regulation of the b-catenin -TCF pathway is associated with differentiation of the Caco-2 colon carcinoma cell line (Mariadason et al., 2001) . The major role of b-catenin stabilization in colorectal carcinogenesis could be other than the conferring of growth advantages and requires further investigation. Downregulation of b-catenin or TCF/LEF-dependent transcription as a therapeutic target in colorectal carcinomas should be carefully re-evaluated.
Materials and methods
Cell culture
HCT116 cells were obtained from the American Type Culture Collection (Rockville, MD, USA) and maintained in Dulbecco's modified Eagle's medium (Sigma Chemical Co., St. Louis, MO, USA) supplemented with 10% fetal bovine serum. Culture medium supplemented with 0.1% fetal bovine serum was used to examine growth under low serum conditions.
Gene targeting
A lambda Fix II genomic library prepared from human placenta (Stratagene, La Jolla, CA, USA) was screened with a b-catenin exon 2 DNA fragment as a probe. One of the isolated clones was partially sequenced, and primers to generate 5' and 3' arms for the promoterless replacement type targeting vector were designed. The primers used were 5'-GGAGgcggccgcTGCAGTGAGCCCAGTATGCAC-3' (forward) and 5'-CaagcttAGCCATTGTCCACGCTGGAT-TT-3' (reverse) for the 5' arm, and 5'-AGAgtcgacTTTTT-CATTGCCTTACTGAAAGTC-3' (forward) and 5'-ATCTATggtaccAAAGCTGGAATAAAGCAT-3' (reverse) for the 3' arm. Each primer contained additional restriction enzyme sites for subcloning (indicated by lower-case letters). PCR was performed with isolated b-catenin genomic clone as a template. The resulting products (1.2 and 8 kbp on the 5' and 3' arms, respectively) were subcloned into the pCR II plasmid vector using a TOPO TA cloning kit (Invitrogen, Carlsbad, CA, USA). For construction of the targeting vector, the promoterless puromycin resistance gene without the first ATG was subcloned into the HindIII -ClaI site of pBluescript II SK Phagemid (Stratagene). Subsequently, the NotIHindIII fragment of the 5' arm and the SalI -KpnI fragment of the 3' arm were subcloned into the NotI -HindIII site and the XhoI -KpnI site respectively. The puromycin resistance gene was placed in-frame into exon 2 of the b-catenin gene downstream of the first ATG (Figure 1a) . HCT116 cells were plated on 100-mm dishes at a concentration of 3610 6 /dish 24 h before transfection. The targeting vector was linearized by NotI digestion and transfection was performed with FuGENE 6 (Roche Diagnostics, Germany) according to the manufacturer's protocol. After 2 days, puromycin (2 mg/ml) was added to the medium. At 2 weeks after transfection, independent colonies were cloned and expanded in medium that contained puromycin.
Genomic DNA of the puromycin-resistant clones was extracted by a standard protocol and subjected to PCR analysis to screen homologous recombination events, using primer F (5'-AGGTGGTGAAGTAGTTACATAGCCAC-TC-3') located upstream of the targeting vector sequence and primer R (5'-TTGCAGCTCGGTGACCCGCTCGATG-TGG-3') located in the puromycin resistance gene ( Figure  1a) . For Southern blotting, 20 mg of genomic DNA was digested with BamHI, separated on 1% agarose gel, and transferred to Hybond N (Amersham Life Science, UK). The membrane was probed with a 32 P-labeled genomic DNA fragment corresponding to b-catenin exons 4 -6. Sequence analysis of exon 3 of the b-catenin gene was performed by direct sequencing as described previously (Sekine et al., 2002) .
Northern blotting
Total RNA (15 mg/lane) was separated on 1% agarose gel and transferred to Hybond N (Amersham Life Science). Hybridization was performed with a 32 P-labeled genomic DNA fragment corresponding to b-catenin exons 4 -6. The quality and quantity of electrophoresed RNA was determined by hybridization with G3PDH cDNA (Clonetech, Palo Alto, CA, USA).
Western blotting
Subconfluent cells were washed twice in ice-cold PBS and incubated in 0.5% NP40 lysis buffer (NP40, 0.5%; Tris-HCl pH 7.5, 50 mM; NaCl, 100 mM; proteinase inhibitor, Complete (Roche Diagnostics)) for 30 min on ice. Lysates were clarified by centrifugation at 14 0006g for 30 min and the soluble supernatant was collected. The pellets, representing the NP40-insoluble fraction, were incubated in SDS lysis buffer (SDS, 1%; Tris-HCl, pH 7.5, 15 mM; EDTA, 2 mM; protease inhibitor) at 1008C for 30 min. The protein concentration of each fraction was determined by DC Protein assay (Bio-Rad, Hercules, CA, USA). Samples (5 mg of protein) were denatured, electrophoresed in 7.5% SDS -PAGE gels and then transferred to Immobilon-P membranes (Millipore, MA, USA). The blot was detected by anti-bcatenin antibody (#C19220; Transduction Laboratories, Lexington, KY, USA). Horseradish peroxidase-conjugated goat anti-mouse IgG (IBL, Japan) was used as secondary antibody, and immune complexes were detected using the ECL system (Amersham Life Science).
Luciferase reporter assay
To evaluate TCF/LEF-dependent transcriptional activity, a luciferase reporter assay was performed with a pair of luciferase reporter constructs TOP -FLASH and FOP -FLASH (Upstate Biotechnology, Lake Placid, NY, USA), as described previously (Naishiro et al., 2001) . TOP -FLASH contains three copies of the TCF/LEF binding sites, and FOP -FLASH contains mutated TCF/LEF binding sites. Cells were transiently transfected in triplicate with one of these luciferase reporters and pRL-TK (Promega, Madison, WI, USA) by use of Fugene 6 (Roche). Luciferase activity was measured with the Dual-luciferase reporter assay system (Promega), with the Renilla luciferase activity as an internal control, 48 h after transfection.
Characterization of cell growth in vitro
Cells 1610 5 were plated into 6-well microtiter plates. Three wells were trypsin-treated at each time point, and cells were counted in a Cell Counter (Beckman Coulter, CA, USA).
Soft agar colony-forming assay
The soft agar colony-forming assay was performed as described previously to evaluate anchorage-independent growth (Naishiro et al., 2001) . Cells 5610 3 were suspended in 1 ml of 0.3% molten top agarose, and overlaid onto 1 ml of 0.5% solid bottom agarose in each well of 6-well tissue culture clusters. After solidification, the top agarose was covered with 1 ml of culture medium. At 10 days after plating, colonies were photographed by phase-contrast microscopy and their images were captured with the NIH Image software program. The areas of 30 colonies were calculated. Data were represented as ratios to parental HCT116 and as means+s.d.
Characterization of cell growth in vivo
Cells were harvested before inoculation and resuspended in serum-free medium at a concentration of 2.5610 7 cells/ml. Cells (2.5610 6 cells, 0.1 ml) were then inoculated subcutaneously into the back of 6-week-old female athymic nu/nu mice (four mice for each clone). After 2 weeks, the mice were sacrificed and their tumors were weighed. Differences between groups were analysed with Student's t-test and were considered significant when the P value was less than 0.05.
